Vanda Pharmaceuticals, Inc. (VNDA)
6.97
-0.03
(-0.43%)
USD |
NASDAQ |
Apr 06, 16:00
6.91
-0.06
(-0.86%)
After-Hours: 20:00
Vanda Pharmaceuticals SG&A Expense (TTM) : 237.95M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 8.398B |
| Eli Lilly & Co. | 11.09B |
| Gossamer Bio, Inc. | 37.63M |
| Arcellx, Inc. | 117.76M |
| AnaptysBio, Inc. | 50.74M |